Astrazeneca First-Half 2015 Results
AstraZeneca will announce first-half 2015 results on Thursday, 30 July with a scheduled Stock Exchange release time of 07:00BST (08:00CEST, 02:00am EDT).
Shortly after the results have been announced we will be sending out the press release via email. It will also be available on the AstraZeneca Investor Relations website http://www.astrazeneca.com/investors/ .
An analyst presentation of the second quarter & half year results will take place at 12:00BST (13:00CEST, 07:00AM EDT) and will be accessible by a choice of two routes.
You can pre-register and test the webcast using this link http://edge.media-server.com/m/s/6ev3meec/lan/en.
During the Q&A session you will be able to email questions to the presenters. If you wish to take part in the Q&A session live rather than by email you will need to dial into the teleconference, details below.
An indexed version of the webcast will be available from 17:30BST on Thursday 30 July on http://www.astrazeneca.com/investors/.
If you wish to listen to the analyst presentation and take part in the Q&A session, please see the details below:
UK (freephone): 0800 694 2370
International: +44 1452 557749
Sweden (freephone): 0200 883 079
US (freephone): 1 866 977 7645
Conference ID: 75191806
To ensure that you don’t miss the start of the teleconference please dial into the call 5 minutes early.
Pdf versions of slides will be available to download on the AstraZeneca Investor Relations website http://www.astrazeneca.com/investors/ no later than 15 minutes before the analyst presentation begins.
A recording of the analyst presentation and Q&A session will be available until 13:30BST Wednesday 12 August, on the following numbers:
UK (freephone): 0800 953 1533
International: +44 1452 55 00 00
US (freephone): 1 866 247 4222
Conference ID: 75191806
American Society of Clinical Oncology (ASCO) Annual Meeting
1 June 2015
AstraZeneca will be hosting a briefing for analysts and investors during the American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago on Monday 1 June 2015, from 8:30pm –10:00pm CDT (2 June 2:30am - 4:00am BST – UK). The aim of this event is to update on progress with AstraZeneca’s immuno-oncology pipeline and combination treatments.
You will be able to listen to the event using the following dial in details:
UK freephone: 0800 694 0257
US freephone: 866 966 9439
Sweden freephone: 0200 890171
International: +44 (0) 1452 555566
Conference code: 42762226